Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

MA Nauck, G Meininger, D Sheng, L Terranella, PP Stein, Jorma Lahtela

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Pages (from-to)194-205
JournalDiabetes Obes Metab
Issue number2
Publication statusPublished - 2007
Publication typeA1 Journal article-refereed

Cite this